Drugs Made In America Acquisition Corp. Rights
$0.14
-0.00 (-0.93%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- -13.0%
- 3 Months
- +24.7%
- YTD
- -25.9%
- 1 Year
- -22.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 136.3%
- Largest decline max drawdown, since Aug 2025
- -81.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.43
Own DMAAR?
See how DMAAR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.